IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Puissance Capital Management LP

Q4 2018 Holdings

Filed 2019-02-14 | 7 holdings | $1.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Corvus Pharmaceuticals Inc(CRVS)COM221015100$1.0M284,86992.3%
Viewray Inc(VRAYQ)COM92672L107$41.5K6,842,9753.7%
Ekso Bionics Hldgs IncCOM NEW282644202$25.5K20,534,8982.3%
Kadmon Hldgs Inc(KDMN)COM48283N106$9.4K4,499,3520.8%
Bellerophon Therapeutics Inc(BLPHEUR)COM078771102$6.7K8,298,7550.6%
Tracon Pharmaceuticals IncCOM89237H100$2.9K4,601,7680.3%
Spdr Series Trust(XBI)S&P BIOTECH78464A870$7169,9860.1%